Andrew Williams

Andrew Williams

McDonnell Boehnen Hulbert & Berghoff LLP


Latest Publications

Share:

When NPR Podcasters Hit the Patent System

There has been a lot of discussion recently in the mainstream press regarding the U.S. patent system and its perceived failings. The current outcries stem from the apparent proliferation of "Patent Trolls," also known by the...more

6/13/2013 - NPR Patent Trolls Patents Podcasts

"When the Patent System is Attacked!" -- The White House Task Force on High-Tech Patent Issues

On February 14, 2013, President Obama stated in reference to non-practicing Patent Assertion Entities ("PAEs") (aka "Patent Trolls") "they don't actually produce anything themselves. ...more

6/5/2013 - Barack Obama Non-Practicing Entities Patent Reform Patent Trolls Patents USPTO

Aventis Pharmaceuticals Inc. v. Amino Chemicals Ltd. (Fed. Cir. 2013)

Can the claim term "substantially pure" mean two different things when the specification uses the same term to refer to both an intermediate compound and a final drug product in a specification? ...more

6/4/2013 - Derivatives Patents Pharmaceutical Prior Art

Supreme Court Grants Certiorari in Medtronic v. Boston Scientific

On May 20, 2013, the Supreme Court granted certiorari in the Medtronic Inc. v. Boston Scientific Corp. case (Supreme Court docket number 12-1128). The sole issue on appeal is encapsulated by the question presented...more

5/23/2013 - Certiorari Licenses Medtronic v Boston Scientific Medtronics Patents SCOTUS

Allergan, Inc. v. Sandoz Inc. (Fed. Cir. 2013)

Can a method of treatment claim be inherent in the prior art if neither the formulation nor the method of using the formulation twice a day were in the prior art? ...more

5/2/2013 - Allergan Inc Patents Prescription Drugs Prior Art

USPTO Publishes Final Rules Adopting the New USPTO Rules of Professional Conduct

The United States Patent and Trademark Office (“USPTO”) published its final rules in the April 3, 2013 Federal Register in preparation for adopting the new USPTO Rules of Professional Conduct (“USPTO Rules”). These new rules...more

4/4/2013 - Final Rules Model Rules of Professional Conduct USPTO

In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation (Fed. Cir. 2013)

On the first day of February, the Federal Circuit rejected Impax's efforts to get out from under a preliminary injunction in a case captioned In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation. ...more

3/1/2013 - ANDA Cephalon Drug Manufacturers Generic Drugs Hatch-Waxman Manufacturers Mylan Pharmaceuticals Patents Prescription Drugs Sales Contracts Settlement Watson Pharmaceuticals

In re Rosuvastatin Calcium Patent Litigation (Fed. Cir. 2012)

Late last year, in AstraZeneca v. Aurobindo (In re Rosuvastatin Calcium Patent Litigation), the Federal Circuit affirmed that a reissue patent covering the active ingredient of Crestor® was valid, enforceable, and infringed...more

1/10/2013 - ANDA AstraZeneca Crestor Hatch-Waxman Patents Pharmaceutical Rosuvastatin

×

Expand Your Reach

JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...

Learn More  or  Schedule a demo

Start a limited-feature trial account (individuals only).